Related Experiment Videos
Elementary pharmacokinetics in clinical practice 4: genetic, environmental and age influences on pharmacokinetics
The New Zealand Medical Journal
|December 9, 1981
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (AS1404), a novel vascular disrupting agent, in phase I clinical trial.
Cancer chemotherapy and pharmacology·2006
Species differences in the metabolism of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid in vitro: implications for prediction of metabolic interactions in vivo.
Xenobiotica; the fate of foreign compounds in biological systems·2002
Identification and reactivity of the major metabolite (beta-1-glucuronide) of the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in humans.
Xenobiotica; the fate of foreign compounds in biological systems·2001
Effects of anticancer drugs on the metabolism of the anticancer drug 5,6-dimethylxanthenone-4-acetic (DMXAA) by human liver microsomes.
British journal of clinical pharmacology·2001
How can we value what is not measured: the need for better data on women's health and primary care.
The New Zealand medical journal·2026
Public support for cancer prevention and care policies in Aotearoa New Zealand: methods of a national survey.
The New Zealand medical journal·2026
Aotearoa New Zealand public strongly support investment in cancer treatment and care services: findings from a national survey.
The New Zealand medical journal·2026
Public support for better controls on lobbying and industry influence in Aotearoa New Zealand: findings from a national survey.
The New Zealand medical journal·2026
Exploring the therapeutic potential of Astragalin in Parkinson's disease: a network pharmacology approach.
Annals of medicine and surgery (2012)·2026